Contributor:

and Carl Danzig, MD

Talking to Patients About Treatment Risks

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Why Retina Specialists Are Growing More Comfortable With Early Treatment

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Complement Inhibition Therapy in a Monocular Patient With a New CNV

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Delayed Complement Inhibition Therapy per Patient Request

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Multimodal Imaging for Biomarker Detection in GA Patients

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA in the Presence of Dense Cataract, Followed by CNV Development

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA Patient Who Becomes Monocular Over Time Due to the Wet AMD

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Barriers to Care, Patient Education, and Treatment Decisions in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

ASRS Meeting Coverage Day 1: TALON and TRUCKEE in Wet AMD

Carl Regillo, MD; and Carl Danzig, MD